Delivery Order SPE2DB22D1106-SPE2DB25FELN1
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,136.02, is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,502.01 firm fixed-price delivery order is for the supply of XYLOCAINE 1%-EPI 1:100,000 50ML, a local anesthetic medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Xylocaine-MPF 2% 40 mg/2 ml vials to the Defense Logistics Agency (DLA). The contract, valued at $6,221.86, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 18, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, valued at $1,462.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xylocaine 1%-Epi 1:100,000 50ml, a local anesthetic medication. The contract, which has a completion date of December 4, 2023, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYLOCAINE-MPF 2% VIAL 5ML medical products. The $1,370.50 firm fixed-price delivery order has an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication. The contract is a Delivery Order with a Firm Fixed Price of $1,386.88 and an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of XYLOCAINE-MPF 1% VIAL 30ML, a pharmaceutical product. The award, valued at $1,301.92, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XYLOCAINE-MPF 1% VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price delivery order contract has a potential value of $1,042.89 and a period of performance through February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not associated with any set-aside designation. The company has a...
This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3FH9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,037.22 firm fixed-price delivery order is for the pharmaceutical product XYLOCAINE-MPF 2% VIAL 5ML, with an ultimate completion date of October 27, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $7,148.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...